Home » Topics » Disease categories and therapies » Substance use and poisoning

Substance use and poisoning
RSS

Enrollment completed in Nabi Biopharma' second phase III NicVAX trial

Nov. 10, 2010

No Comments

Nicotine vaccine NIC-002 enters phase II study

Nov. 8, 2010

No Comments

AEOL-10150 promotes survival in nonhuman primates exposed to radiation

Nov. 5, 2010

No Comments

Soligenix presents preliminary phase Ib safety data on RiVax

Nov. 4, 2010

No Comments

Alkermes' combination therapy for cocaine addiction to advance to phase II

Oct. 26, 2010

No Comments

Omeros receives additional grant from NIDA for addiction program

Oct. 18, 2010

No Comments

FDA approves Vivitrol for prevention of relapse to opioid dependence

Oct. 13, 2010

No Comments

Embera NeuroTherapeutics obtains NIDA grant for EMB-001 development

Oct. 5, 2010

No Comments

Cleveland BioLabs reports on second safety study of CBLB-502

Oct. 1, 2010

No Comments

FDA approves phase Ib ibudilast trial in methamphetamine-dependent subjects

Sep. 29, 2010

No Comments

BioWorld Premium

Enjoy extended coverage for the most complete market view with BioWorld, BioWorld MedTech, and BioWorld Asia in a single, easy to access subscription.

Substance use and poisoning
RSS

Enrollment completed in Nabi Biopharma' second phase III NicVAX trial

Nicotine vaccine NIC-002 enters phase II study

AEOL-10150 promotes survival in nonhuman primates exposed to radiation

Soligenix presents preliminary phase Ib safety data on RiVax

Alkermes' combination therapy for cocaine addiction to advance to phase II

Omeros receives additional grant from NIDA for addiction program

FDA approves Vivitrol for prevention of relapse to opioid dependence

Embera NeuroTherapeutics obtains NIDA grant for EMB-001 development

Cleveland BioLabs reports on second safety study of CBLB-502

FDA approves phase Ib ibudilast trial in methamphetamine-dependent subjects

Today's news in brief

Today's news in brief

Type 1 diabetes breakthrough? Sana threads key ‘islet,’ SC-451 to advance

Australia’s Celosia heads toward clinic with gene therapy for ALS

Sangamo stock plunges as Pfizer leaves hemophilia partnership

Substance use and poisoning RSS

Substance use and poisoning
RSS